Chemotherapy for Colorectal Cancer

@article{Goyle2005ChemotherapyFC,
  title={Chemotherapy for Colorectal Cancer},
  author={S. Goyle and A. Maraveyas},
  journal={Digestive Surgery},
  year={2005},
  volume={22},
  pages={401 - 414}
}
  • S. Goyle, A. Maraveyas
  • Published 2005
  • Medicine
  • Digestive Surgery
  • Colorectal cancer is the most commonly diagnosed cancer in the EU. Various randomised studies have shown a survival benefit with chemotherapy in the adjuvant setting. Adjuvant chemotherapy with 5-fluorouracil/folinic acid (5FU/FA) for 6 months after curatively resected node-positive colon cancer has become the standard practice. However, controversy still exists regarding the optimal regimen and whether to treat node-negative patients. The latest QUASAR trial results seem to strengthen the… CONTINUE READING
    10 Citations
    Ablative and catheter-delivered therapies for colorectal liver metastases (CRLM).
    • J. Evans
    • Medicine
    • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
    • 2007
    • 23
    Pancreatic adenocarcinoma: putting a hump in survival.
    • P. Allen
    • Medicine
    • Journal of the American College of Surgeons
    • 2007
    • 12

    References

    SHOWING 1-10 OF 110 REFERENCES
    Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.
    • 270
    Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1992
    • 140
    QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients.
    • 129
    Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.
    • 2,818
    • PDF
    Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators.
    • C. Erlichman
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1999
    • 480
    Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.
    • 382
    Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.
    • P. Piedbois
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1992
    • 1,166